2018 annual financial data
Tempest Therapeutics 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -23,116,000 USD and net income was -27,192,000 USD.
Operating cash flow was -23,647,000 USD.
Get free Tempest Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -23,116,000 USD
- Net income
- -27,192,000 USD
- Operating cash flow
- -23,647,000 USD